Screener
UroGen Pharma URGN Business Segments — Professional Fees
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:ProfessionalFees.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
FAQ
- What is UroGen Pharma's business segments — professional fees?
- UroGen Pharma (URGN) reported business segments — professional fees of $3.69M in Q2 2026.
- What does business segments — professional fees mean?
- This metric captures payments made to external third-party service providers, including legal counsel, accounting firms, and specialized consultants. These fees are often incurred for regulatory compliance, intellectual property protection, or strategic advisory services. It serves as a measure of the company's reliance on external expertise to navigate complex regulatory and legal environments.
Ask your AI about UroGen Pharma's business segments — professional fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude